agilon health (NYSE:AGL) Raised to “Outperform” at Sanford C. Bernstein

agilon health (NYSE:AGL) was upgraded by Sanford C. Bernstein from a “market perform” rating to an “outperform” rating in a report released on Tuesday, Marketbeat Ratings reports. The firm presently has a $8.50 price target on the stock, up from their prior price target of $3.30. Sanford C. Bernstein’s price objective would indicate a potential upside of 64.09% from the company’s current price.

Several other research firms also recently weighed in on AGL. Macquarie assumed coverage on shares of agilon health in a report on Monday, December 16th. They issued a “neutral” rating and a $3.00 target price for the company. Citigroup raised agilon health from a “sell” rating to a “neutral” rating and lifted their price objective for the company from $1.75 to $2.25 in a research note on Friday, January 10th. Stifel Nicolaus increased their target price on agilon health from $2.00 to $3.00 and gave the stock a “hold” rating in a research note on Wednesday, February 26th. Royal Bank of Canada lifted their target price on agilon health from $3.00 to $3.50 and gave the company an “outperform” rating in a research report on Wednesday, February 26th. Finally, Needham & Company LLC reissued a “hold” rating on shares of agilon health in a research report on Friday, March 21st. Two investment analysts have rated the stock with a sell rating, twelve have assigned a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $4.37.

agilon health Trading Down 3.4 %

Shares of AGL stock opened at $5.18 on Tuesday. agilon health has a 1-year low of $1.50 and a 1-year high of $7.73. The firm has a market cap of $2.14 billion, a PE ratio of -5.51 and a beta of 0.38. The company has a 50-day moving average of $3.90 and a two-hundred day moving average of $3.05. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29.

Institutional Investors Weigh In On agilon health

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Oak Thistle LLC acquired a new position in agilon health in the fourth quarter valued at approximately $25,000. Ieq Capital LLC acquired a new stake in agilon health during the 4th quarter worth $26,000. Signaturefd LLC lifted its position in agilon health by 143.0% in the fourth quarter. Signaturefd LLC now owns 14,388 shares of the company’s stock valued at $27,000 after acquiring an additional 8,467 shares during the last quarter. Humankind Investments LLC purchased a new stake in agilon health in the fourth quarter valued at $30,000. Finally, Raymond James Financial Inc. acquired a new position in agilon health in the fourth quarter valued at $33,000.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.